By Philips ∙ Featuring AWS, Policlinico Gemelli ∙ Jan 31, 2023 ∙ 58:44 min
Check out the panel discussion hosted by Philips and hear about leveraging public cloud and generative AI technology to empower the next generation of radiology. We will explore how radiology informatics solutions benefit from secure, compliant cloud technology and can automatically scale to support vast amounts of imaging data. We will also discuss how AI/ML and generative AI in healthcare can serve as a radiologist’s assistant to help enhance diagnostic speed and quality while supporting patient outcomes – all thanks to the public cloud.
Chair, Department of Diagnostic Imaging and Radiotherapy
Policlinico Gemelli
Rome, Italy
Chief Technology Officer Healthcare EMEA
Amazon Web Services (AWS)
Chief Innovation and Strategy Officer and Chief Business Leader of Enterprise Informatics
Philips
Radiology Informatics Business Leader
Philips
[1] Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129. [2] Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59. [3] 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96. Japan guidelines [4] Jeremias A et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 Oct 28;12(20):1991-2001. [5] Patel M., et al. 1-Year outcomes of blinded physiological assessment of residual ischemia after successful PCI. JACC Cardiol Interv. 2022;15(1):52-61. [6] FDA 510k (#K173860). The iFR modality is intended to be used in conjunction with currently marketed Philips pressure wires. In the coronary anatomy, the iFR modality has a diagnostic cut-point of 0.89 which represents an ischemic threshold and can reliably guide revascularization decisions during diagnostic catheterization procedure. [7] Gotberg M. et al. iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI. Late-breaking clinical Trial presentation at TCT on November 4, 2021.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.